ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Coccidiosis Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-12A14206
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Coccidiosis Treatment Market Research Report 2023
BUY CHAPTERS

Global Coccidiosis Treatment Market Research Report 2025

Code: QYRE-Auto-12A14206
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer Animal Health
Boehringer Ingelheim Vetmedica Inc.
Ceva Sante Animale
Intas Pharmaceuticals Ltd
Jurox
Merck Animal Health
Vetoquinol
Virbac
Zoetis Inc
Novartis Animal Healthcare
SmartVet
Huvepharma

Coccidiosis Treatment Market Size

The global market for Coccidiosis Treatment was valued at US$ 141 million in the year 2024 and is projected to reach a revised size of US$ 178 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Coccidiosis Treatment Market

Coccidiosis Treatment Market

Coccidiosis is a parasitic disease of a wide variety of animals caused by coccidian protozoa. The disease spreads from one animal to another by contact with infected feces or ingestion of infected tissue. Diarrhea is the primary symptom of Coccidiosis. Coccidia can infect a wide variety of animals, including humans, birds, and livestock, as they are usually species-specific. The coccidia are responsible for major economic losses of the livestock industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Coccidiosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coccidiosis Treatment.
The Coccidiosis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Coccidiosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coccidiosis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Coccidiosis Treatment Market Report

Report Metric Details
Report Name Coccidiosis Treatment Market
Accounted market size in year US$ 141 million
Forecasted market size in 2031 US$ 178 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Ionophore Drugs
  • Antibiotic Drugs
  • Chemical Derivative Drugs
Segment by Application
  • Poultry
  • Fish
  • Cattle
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Merck Animal Health, Vetoquinol S.A., Virbac S.A., Zoetis, Inc., Novartis Animal Healthcare, Smartvet Inc., Huvepharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Coccidiosis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Coccidiosis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Coccidiosis Treatment Market growing?

Ans: The Coccidiosis Treatment Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Coccidiosis Treatment Market size in 2031?

Ans: The Coccidiosis Treatment Market size in 2031 will be US$ 178 million.

Who are the main players in the Coccidiosis Treatment Market report?

Ans: The main players in the Coccidiosis Treatment Market are Bayer Animal Health, Boehringer Ingelheim Vetmedica, Inc., Ceva Sante Animale, Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Merck Animal Health, Vetoquinol S.A., Virbac S.A., Zoetis, Inc., Novartis Animal Healthcare, Smartvet Inc., Huvepharma

What are the Application segmentation covered in the Coccidiosis Treatment Market report?

Ans: The Applications covered in the Coccidiosis Treatment Market report are Poultry, Fish, Cattle

What are the Type segmentation covered in the Coccidiosis Treatment Market report?

Ans: The Types covered in the Coccidiosis Treatment Market report are Ionophore Drugs, Antibiotic Drugs, Chemical Derivative Drugs

1 Coccidiosis Treatment Market Overview
1.1 Product Definition
1.2 Coccidiosis Treatment by Type
1.2.1 Global Coccidiosis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ionophore Drugs
1.2.3 Antibiotic Drugs
1.2.4 Chemical Derivative Drugs
1.3 Coccidiosis Treatment by Application
1.3.1 Global Coccidiosis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Poultry
1.3.3 Fish
1.3.4 Cattle
1.4 Global Coccidiosis Treatment Market Size Estimates and Forecasts
1.4.1 Global Coccidiosis Treatment Revenue 2020-2031
1.4.2 Global Coccidiosis Treatment Sales 2020-2031
1.4.3 Global Coccidiosis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Coccidiosis Treatment Market Competition by Manufacturers
2.1 Global Coccidiosis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Coccidiosis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Coccidiosis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Coccidiosis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coccidiosis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coccidiosis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Coccidiosis Treatment, Date of Enter into This Industry
2.8 Global Coccidiosis Treatment Market Competitive Situation and Trends
2.8.1 Global Coccidiosis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Coccidiosis Treatment Players Market Share by Revenue
2.8.3 Global Coccidiosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Coccidiosis Treatment Market Scenario by Region
3.1 Global Coccidiosis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Coccidiosis Treatment Sales by Region: 2020-2031
3.2.1 Global Coccidiosis Treatment Sales by Region: 2020-2025
3.2.2 Global Coccidiosis Treatment Sales by Region: 2026-2031
3.3 Global Coccidiosis Treatment Revenue by Region: 2020-2031
3.3.1 Global Coccidiosis Treatment Revenue by Region: 2020-2025
3.3.2 Global Coccidiosis Treatment Revenue by Region: 2026-2031
3.4 North America Coccidiosis Treatment Market Facts & Figures by Country
3.4.1 North America Coccidiosis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Coccidiosis Treatment Sales by Country (2020-2031)
3.4.3 North America Coccidiosis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coccidiosis Treatment Market Facts & Figures by Country
3.5.1 Europe Coccidiosis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Coccidiosis Treatment Sales by Country (2020-2031)
3.5.3 Europe Coccidiosis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coccidiosis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Coccidiosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Coccidiosis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Coccidiosis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coccidiosis Treatment Market Facts & Figures by Country
3.7.1 Latin America Coccidiosis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Coccidiosis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Coccidiosis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coccidiosis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Coccidiosis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Coccidiosis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Coccidiosis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coccidiosis Treatment Sales by Type (2020-2031)
4.1.1 Global Coccidiosis Treatment Sales by Type (2020-2025)
4.1.2 Global Coccidiosis Treatment Sales by Type (2026-2031)
4.1.3 Global Coccidiosis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Coccidiosis Treatment Revenue by Type (2020-2031)
4.2.1 Global Coccidiosis Treatment Revenue by Type (2020-2025)
4.2.2 Global Coccidiosis Treatment Revenue by Type (2026-2031)
4.2.3 Global Coccidiosis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Coccidiosis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Coccidiosis Treatment Sales by Application (2020-2031)
5.1.1 Global Coccidiosis Treatment Sales by Application (2020-2025)
5.1.2 Global Coccidiosis Treatment Sales by Application (2026-2031)
5.1.3 Global Coccidiosis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Coccidiosis Treatment Revenue by Application (2020-2031)
5.2.1 Global Coccidiosis Treatment Revenue by Application (2020-2025)
5.2.2 Global Coccidiosis Treatment Revenue by Application (2026-2031)
5.2.3 Global Coccidiosis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Coccidiosis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer Animal Health
6.1.1 Bayer Animal Health Company Information
6.1.2 Bayer Animal Health Description and Business Overview
6.1.3 Bayer Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Animal Health Coccidiosis Treatment Product Portfolio
6.1.5 Bayer Animal Health Recent Developments/Updates
6.2 Boehringer Ingelheim Vetmedica, Inc.
6.2.1 Boehringer Ingelheim Vetmedica, Inc. Company Information
6.2.2 Boehringer Ingelheim Vetmedica, Inc. Description and Business Overview
6.2.3 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product Portfolio
6.2.5 Boehringer Ingelheim Vetmedica, Inc. Recent Developments/Updates
6.3 Ceva Sante Animale
6.3.1 Ceva Sante Animale Company Information
6.3.2 Ceva Sante Animale Description and Business Overview
6.3.3 Ceva Sante Animale Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Ceva Sante Animale Coccidiosis Treatment Product Portfolio
6.3.5 Ceva Sante Animale Recent Developments/Updates
6.4 Intas Pharmaceuticals Ltd.
6.4.1 Intas Pharmaceuticals Ltd. Company Information
6.4.2 Intas Pharmaceuticals Ltd. Description and Business Overview
6.4.3 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product Portfolio
6.4.5 Intas Pharmaceuticals Ltd. Recent Developments/Updates
6.5 Jurox Pty Ltd.
6.5.1 Jurox Pty Ltd. Company Information
6.5.2 Jurox Pty Ltd. Description and Business Overview
6.5.3 Jurox Pty Ltd. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jurox Pty Ltd. Coccidiosis Treatment Product Portfolio
6.5.5 Jurox Pty Ltd. Recent Developments/Updates
6.6 Merck Animal Health
6.6.1 Merck Animal Health Company Information
6.6.2 Merck Animal Health Description and Business Overview
6.6.3 Merck Animal Health Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Animal Health Coccidiosis Treatment Product Portfolio
6.6.5 Merck Animal Health Recent Developments/Updates
6.7 Vetoquinol S.A.
6.7.1 Vetoquinol S.A. Company Information
6.7.2 Vetoquinol S.A. Description and Business Overview
6.7.3 Vetoquinol S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Vetoquinol S.A. Coccidiosis Treatment Product Portfolio
6.7.5 Vetoquinol S.A. Recent Developments/Updates
6.8 Virbac S.A.
6.8.1 Virbac S.A. Company Information
6.8.2 Virbac S.A. Description and Business Overview
6.8.3 Virbac S.A. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Virbac S.A. Coccidiosis Treatment Product Portfolio
6.8.5 Virbac S.A. Recent Developments/Updates
6.9 Zoetis, Inc.
6.9.1 Zoetis, Inc. Company Information
6.9.2 Zoetis, Inc. Description and Business Overview
6.9.3 Zoetis, Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zoetis, Inc. Coccidiosis Treatment Product Portfolio
6.9.5 Zoetis, Inc. Recent Developments/Updates
6.10 Novartis Animal Healthcare
6.10.1 Novartis Animal Healthcare Company Information
6.10.2 Novartis Animal Healthcare Description and Business Overview
6.10.3 Novartis Animal Healthcare Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Animal Healthcare Coccidiosis Treatment Product Portfolio
6.10.5 Novartis Animal Healthcare Recent Developments/Updates
6.11 Smartvet Inc.
6.11.1 Smartvet Inc. Company Information
6.11.2 Smartvet Inc. Description and Business Overview
6.11.3 Smartvet Inc. Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Smartvet Inc. Coccidiosis Treatment Product Portfolio
6.11.5 Smartvet Inc. Recent Developments/Updates
6.12 Huvepharma
6.12.1 Huvepharma Company Information
6.12.2 Huvepharma Description and Business Overview
6.12.3 Huvepharma Coccidiosis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Huvepharma Coccidiosis Treatment Product Portfolio
6.12.5 Huvepharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coccidiosis Treatment Industry Chain Analysis
7.2 Coccidiosis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coccidiosis Treatment Production Mode & Process Analysis
7.4 Coccidiosis Treatment Sales and Marketing
7.4.1 Coccidiosis Treatment Sales Channels
7.4.2 Coccidiosis Treatment Distributors
7.5 Coccidiosis Treatment Customer Analysis
8 Coccidiosis Treatment Market Dynamics
8.1 Coccidiosis Treatment Industry Trends
8.2 Coccidiosis Treatment Market Drivers
8.3 Coccidiosis Treatment Market Challenges
8.4 Coccidiosis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer Animal Health
Boehringer Ingelheim Vetmedica Inc.
Ceva Sante Animale
Intas Pharmaceuticals Ltd
Jurox
Merck Animal Health
Vetoquinol
Virbac
Zoetis Inc
Novartis Animal Healthcare
SmartVet
Huvepharma
List of Tables
 Table 1. Global Coccidiosis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Coccidiosis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Coccidiosis Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Coccidiosis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Coccidiosis Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Coccidiosis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Coccidiosis Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Coccidiosis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Coccidiosis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Coccidiosis Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Coccidiosis Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Coccidiosis Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Coccidiosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coccidiosis Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Coccidiosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Coccidiosis Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Coccidiosis Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Coccidiosis Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Coccidiosis Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Coccidiosis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Coccidiosis Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Coccidiosis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Coccidiosis Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Coccidiosis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Coccidiosis Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Coccidiosis Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Coccidiosis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Coccidiosis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Coccidiosis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Coccidiosis Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Coccidiosis Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Coccidiosis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Coccidiosis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Coccidiosis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Coccidiosis Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Coccidiosis Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Coccidiosis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Coccidiosis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Coccidiosis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Coccidiosis Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Coccidiosis Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Coccidiosis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Coccidiosis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Coccidiosis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Coccidiosis Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Coccidiosis Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Coccidiosis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Coccidiosis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Coccidiosis Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Coccidiosis Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Coccidiosis Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Coccidiosis Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Coccidiosis Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Coccidiosis Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Coccidiosis Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Coccidiosis Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Coccidiosis Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Coccidiosis Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Coccidiosis Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Coccidiosis Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Coccidiosis Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Coccidiosis Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Coccidiosis Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Coccidiosis Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Coccidiosis Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Coccidiosis Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Coccidiosis Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Coccidiosis Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. Bayer Animal Health Company Information
 Table 71. Bayer Animal Health Description and Business Overview
 Table 72. Bayer Animal Health Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Animal Health Coccidiosis Treatment Product
 Table 74. Bayer Animal Health Recent Developments/Updates
 Table 75. Boehringer Ingelheim Vetmedica, Inc. Company Information
 Table 76. Boehringer Ingelheim Vetmedica, Inc. Description and Business Overview
 Table 77. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim Vetmedica, Inc. Coccidiosis Treatment Product
 Table 79. Boehringer Ingelheim Vetmedica, Inc. Recent Developments/Updates
 Table 80. Ceva Sante Animale Company Information
 Table 81. Ceva Sante Animale Description and Business Overview
 Table 82. Ceva Sante Animale Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Ceva Sante Animale Coccidiosis Treatment Product
 Table 84. Ceva Sante Animale Recent Developments/Updates
 Table 85. Intas Pharmaceuticals Ltd. Company Information
 Table 86. Intas Pharmaceuticals Ltd. Description and Business Overview
 Table 87. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Intas Pharmaceuticals Ltd. Coccidiosis Treatment Product
 Table 89. Intas Pharmaceuticals Ltd. Recent Developments/Updates
 Table 90. Jurox Pty Ltd. Company Information
 Table 91. Jurox Pty Ltd. Description and Business Overview
 Table 92. Jurox Pty Ltd. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Jurox Pty Ltd. Coccidiosis Treatment Product
 Table 94. Jurox Pty Ltd. Recent Developments/Updates
 Table 95. Merck Animal Health Company Information
 Table 96. Merck Animal Health Description and Business Overview
 Table 97. Merck Animal Health Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck Animal Health Coccidiosis Treatment Product
 Table 99. Merck Animal Health Recent Developments/Updates
 Table 100. Vetoquinol S.A. Company Information
 Table 101. Vetoquinol S.A. Description and Business Overview
 Table 102. Vetoquinol S.A. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Vetoquinol S.A. Coccidiosis Treatment Product
 Table 104. Vetoquinol S.A. Recent Developments/Updates
 Table 105. Virbac S.A. Company Information
 Table 106. Virbac S.A. Description and Business Overview
 Table 107. Virbac S.A. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Virbac S.A. Coccidiosis Treatment Product
 Table 109. Virbac S.A. Recent Developments/Updates
 Table 110. Zoetis, Inc. Company Information
 Table 111. Zoetis, Inc. Description and Business Overview
 Table 112. Zoetis, Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zoetis, Inc. Coccidiosis Treatment Product
 Table 114. Zoetis, Inc. Recent Developments/Updates
 Table 115. Novartis Animal Healthcare Company Information
 Table 116. Novartis Animal Healthcare Description and Business Overview
 Table 117. Novartis Animal Healthcare Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Novartis Animal Healthcare Coccidiosis Treatment Product
 Table 119. Novartis Animal Healthcare Recent Developments/Updates
 Table 120. Smartvet Inc. Company Information
 Table 121. Smartvet Inc. Description and Business Overview
 Table 122. Smartvet Inc. Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Smartvet Inc. Coccidiosis Treatment Product
 Table 124. Smartvet Inc. Recent Developments/Updates
 Table 125. Huvepharma Company Information
 Table 126. Huvepharma Description and Business Overview
 Table 127. Huvepharma Coccidiosis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Huvepharma Coccidiosis Treatment Product
 Table 129. Huvepharma Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Coccidiosis Treatment Distributors List
 Table 133. Coccidiosis Treatment Customers List
 Table 134. Coccidiosis Treatment Market Trends
 Table 135. Coccidiosis Treatment Market Drivers
 Table 136. Coccidiosis Treatment Market Challenges
 Table 137. Coccidiosis Treatment Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Coccidiosis Treatment
 Figure 2. Global Coccidiosis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Coccidiosis Treatment Market Share by Type: 2024 & 2031
 Figure 4. Ionophore Drugs Product Picture
 Figure 5. Antibiotic Drugs Product Picture
 Figure 6. Chemical Derivative Drugs Product Picture
 Figure 7. Global Coccidiosis Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Coccidiosis Treatment Market Share by Application: 2024 & 2031
 Figure 9. Poultry
 Figure 10. Fish
 Figure 11. Cattle
 Figure 12. Global Coccidiosis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Coccidiosis Treatment Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Coccidiosis Treatment Sales (2020-2031) & (K Units)
 Figure 15. Global Coccidiosis Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 16. Coccidiosis Treatment Report Years Considered
 Figure 17. Coccidiosis Treatment Sales Share by Manufacturers in 2024
 Figure 18. Global Coccidiosis Treatment Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Coccidiosis Treatment Players: Market Share by Revenue in Coccidiosis Treatment in 2024
 Figure 20. Coccidiosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Coccidiosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Coccidiosis Treatment Sales Market Share by Country (2020-2031)
 Figure 23. North America Coccidiosis Treatment Revenue Market Share by Country (2020-2031)
 Figure 24. United States Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Coccidiosis Treatment Sales Market Share by Country (2020-2031)
 Figure 27. Europe Coccidiosis Treatment Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Coccidiosis Treatment Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Coccidiosis Treatment Revenue Market Share by Region (2020-2031)
 Figure 35. China Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Coccidiosis Treatment Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Coccidiosis Treatment Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Coccidiosis Treatment Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Coccidiosis Treatment Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Coccidiosis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Coccidiosis Treatment by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Coccidiosis Treatment by Type (2020-2031)
 Figure 54. Global Coccidiosis Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Coccidiosis Treatment by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Coccidiosis Treatment by Application (2020-2031)
 Figure 57. Global Coccidiosis Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 58. Coccidiosis Treatment Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Coccidiosis Vaccines Market Research Report 2024
Global Poultry Coccidiosis Vaccines Market Research Report 2025
Global Coccidiosis Treatment Solution Market Research Report 2024
Global Anticoccidial Solutions Market Research Report 2024
Global Coccidia Virus Live Vaccine Market Research Report 2025
Global Coccidiosis Vaccines in Chickens Market Research Report 2024
Global Coccidiosis Vaccine for Chickens Market Research Report 2024
Coccidiostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Animal Internal Parasiticide Market Insights Forecast to 2030
Global Parasiticide for Animal Market Research Report 2024
Global Amebiasis Market Insights Forecast to 2030
Global Amebiasis Treatment Market Insights Forecast to 2030
Global Cryptococcosis Drugs Market Insights Forecast to 2030
Feed Anticoccidials for Ruminants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclospora Diagnostic Testing Market Insights Forecast to 2030
Global Farm Animal Internal Parasiticide Market Insights Forecast to 2030
Global Livestock Animal Parasiticides Market Insights Forecast to 2030
Global Amebiasis Therapeutics Market Insights Forecast to 2030
Global Amebiasis Drugs Market Insights Forecast to 2030
Animal Parasiticide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions